Time course of changes in lipid profile measures in patients with early psoriatic arthritis during adalimumab therapy
Patients with psoriatic arthritis (PsA) have a higher risk of cardiovascular disease (CVD) compared with the general population. Inflammation and traditional CVD risk factors (RFs), including dyslipidemia, make a significant contribution to the development of CVD and their complications in patients...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IMA PRESS LLC
2019-11-01
|
Series: | Научно-практическая ревматология |
Subjects: | |
Online Access: | https://rsp.mediar-press.net/rsp/article/view/2781 |